Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$9.12 - $18.9 $1.78 Million - $3.69 Million
195,000 Added 8.8%
2,409,961 $23.2 Million
Q1 2022

May 16, 2022

SELL
$12.15 - $16.83 $12.2 Million - $16.9 Million
-1,002,202 Reduced 31.15%
2,214,961 $37.3 Million
Q4 2021

Feb 14, 2022

BUY
$13.83 - $18.78 $6.46 Million - $8.77 Million
467,026 Added 16.98%
3,217,163 $53.8 Million
Q3 2021

Nov 15, 2021

BUY
$7.07 - $17.5 $7.08 Million - $17.5 Million
1,001,896 Added 57.31%
2,750,137 $44.7 Million
Q2 2021

Aug 16, 2021

BUY
$5.69 - $7.17 $109,248 - $137,664
19,200 Added 1.11%
1,748,241 $11 Million
Q1 2021

May 17, 2021

BUY
$5.08 - $6.89 $2.31 Million - $3.13 Million
454,780 Added 35.69%
1,729,041 $10.7 Million
Q4 2020

Feb 16, 2021

BUY
$5.65 - $7.66 $7.2 Million - $9.76 Million
1,274,261 New
1,274,261 $8.81 Million

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.